Blood and lymphatic treatment supply 'is inconsistent'

Primary care organisations (PCOs) are failing to provide NICE-approved treatments for blood and lymphatic treatments, research by Leukaemia Care suggests.

The charity reports that only 42% of PCOs in England and Wales make funding for blood and lymphatic treatments available as soon as guidance is issued.

In 22% of PCOs funding was not available 90 days after guidance was issued, according to the Leukaemia Care's 2009 haematology services survey. The charity is calling for a consistent and transparent approach to providing treatment across England and Wales.

Tony Gavin, director of cancer campaigning and advocacy at Leukaemia Care, said one of the charity's greatest concerns was that patients should have access to treatment. 

‘This report shows that some cost effective treatments are not always being made available to patients and that confusion over the stages at which treatments can be made available is delaying vital treatment by as much as 90 days — days that some patients just don't have,' he said.

  • Do you agree that this is a problem?


More news from 20 August

Exclusive: Practices lose £30,000 on extended hours
Backing for shadow health minister advising private GP firm
Nurses back NICE on cholesterol management
Unite suggests fast-track route into health visiting

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Follow Us: